Received Mar 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 2 | yo14585 | IM / LL |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | yo13132 | SC / RL |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | yoo6524 | SC / LL |
Patient turn blue and unresponsive immediately after given the vaccines, vitals were taken and patient O2sats was 100% so no oxygen was administered. ,patient was observed here in the office for about 45 mins and checked multiple times by the Doctor.
none
Pulmonary vein stenosis Complete atrioventricular septal defect (CAVSD) Complete AV canal Pulmonary hypertension Pulmonary vein atresia Long-term current use of sirolimus Right atrioventricular valve regurgitation Left atrioventricular valve regurgitation Secundum ASD FTT (failure to thrive) in child Speech and language developmental delay Constipation Intermittent exotropia, alternating Amblyopia, right eye Corneal scar, right eye
Last Edited Aspirin 1 week ago Chlorothiazide 1 week ago Furosemide 1 week ago Furosemide 3 weeks ago Polyethylene Glycol 3350 1 week ago Sirolimus 1 week ago Sulfamethoxazole-Trimethoprim
none
none